ProVerum Achieves Milestone with Successful Use of ProVee® System in U.S. for BPH Treatment
ProVerum Limited Marks Major Achievement in BPH Treatment
Dublin-based ProVerum Limited has successfully completed its first commercial procedures using the innovative ProVee® System for benign prostatic hyperplasia (BPH) in the United States. This development is a significant step not only for ProVerum but also for the countless men suffering from BPH.
A Breakthrough in Treatment Options
BPH is a common condition, affecting more than 12 million men in the U.S. alone, leading to symptoms such as frequent urination, weakened urine flow, and the inability to completely empty the bladder. These issues often degrade the quality of life for those affected. ProVerum’s ProVee System offers a minimally invasive alternative to traditional surgical options, making it a valuable addition to the treatment landscape.
The ProVee System is designed to gently open the obstructed prostate without cutting or causing damage to surrounding tissue, which can lead to a quicker recovery for patients. With its approval from the FDA, ProVerum aims to transform the treatment experience for BPH patients throughout the country.
Successful Initial Procedures
The initial procedures were performed by experienced urologists at various practices across the nation, showcasing the growing interest in innovative and less invasive treatments. Notable physicians who participated in these landmark cases include:
- - Dr. Tyler McClintock at Midtown Urology Associates
- - Dr. Michael Trotter at Midtown Urology Associates
- - Dr. Brian Mazzarella at Urology Austin
- - Dr. Ricardo Gonzalez at Houston Methodist
- - Dr. Sijo Parekattil at Avant Concierge Urology
- - Dr. Raviender Bukkapatnam at Florida Urology Partners
- - Dr. Sheldon Freedman at Freedman Urology
- - Dr. Ning Wu at Comprehensive Urologic Care
Paul Bateman, CEO of ProVerum, remarked on the impact of these successful procedures: “Our first procedures in the U.S. not only mark a significant milestone for ProVerum but also address the increasing demand for minimally invasive treatments for BPH.”
The Path Forward
With these first commercial cases completed, ProVerum is poised to advance its clinical adoption efforts and physician training initiatives across the country. By supporting the integration of the ProVee System into urologists' practices, ProVerum aims to enhance treatment options for men suffering from BPH.
The ProVee System symbolizes hope for many patients. As its use expands and clinical outcomes continue to be assessed, ProVerum is dedicated to improving the lives of men dealing with the symptoms of BPH.
For further information about ProVerum and the ProVee System, visit ProVerum Medical or engage with them on platforms like X and LinkedIn.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.